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Abstract
Articular cartilage is often damaged due to trauma or degenerative diseases, resulting in severe
pain and disability. Most clinical approaches have been shown to have limited capacity to treat
cartilage lesions. Tissue engineering (TE) has been proposed as an alternative strategy to repair
cartilage. Cartilage defects often penetrate to the subchondral bone, or full-thickness defects are
also produced in some therapeutic procedures. Therefore, in TE strategies one should also consider
the need for a simultaneous regeneration of both cartilage and subchondral bone in situations
where osteochondral defects are present, or to provide an enhanced support for the cartilage
hybrid construct. In this review, different concepts related to TE in osteochondral regeneration
will be discussed. The focus is on the need to produce new biphasic scaffolds that will provide
differentiated and adequate conditions for guiding the growth of the two tissues, satisfying their
different biological and functional requirements. Copyright  2007 John Wiley & Sons, Ltd.
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1. Introduction
Articular cartilage injuries occur frequently as a result
of trauma, tumour or osteoarthritis (OA). OA is the
most prevalent disorder of the musculoskeletal system,
affecting about 10% of the US population older than
30, and most of the people over the age of 65, with
total direct costs estimated at $28.6 billion/year (Felson
and Zhang, 1998). Besides cartilage, OA also involves
the synovium, joint capsule and subchondral bone. It
is not yet completely clear why the different joints are
not affected equally by this degenerative joint disease;
this issue has been discussed recently by Kuettner and
Cole (2005). However, the main pathological features
of this disease are known and thought to develop as
a result of destruction of cartilage matrix, leading to
a progressive loss in joint function, together with the
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destabilization of supramolecular structures, including the
collagen network, and changes in the expression profile
of matrix molecules (Aigner and McKenna, 2002).
Articular cartilage lesions are typically irreversible, due
to the unique features of this tissue (Temenoff and Mikos,
2000), including its avascular nature and consequent
lack of access to a pool of potential reparative cells and
humoral factors. Also, cartilage has a low cell :matrix
ratio, and mature chondrocytes have a relatively low
metabolic activity that limits any considerable capacity
of remodelling (Hunziker, 2002; Pacifici et al., 2000).
In cases where the lesions do not penetrate to the
subchondral bone, the pluripotent progenitor cells from
the bonemarrow cannot be recruited and the repair will be
limited. On the other hand, full-thickness (osteochondral)
defects go through the subchondral bone, accessing the
bone marrow cells, including mesenchymal stem cells
(Redman et al., 2005) and also growth factors and
cytokines. However, the repair response typically leads
to the formation of fibrocartilage in the defect void
(Shapiro et al., 1993), which is a poor substitute for
articular cartilage, and a degeneration of both repaired
and adjacent native tissues will be often observed after
Copyright  2007 John Wiley & Sons, Ltd.
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long-term follow-up (Buckwalter, 1998; Dounchis et al.,
2000; Shortkroff et al., 1996).
Current treatments of articular cartilage have included:
(a) the creation of a full-thickness defect by abrasion
or drilling, to access to the migration of progenitor cells
(Angel et al., 2003; Shapiro et al., 1993); (b) arthroscopic
lavage and debridement, which eliminates debris from
the joint space or joint surface, alleviating pain
(Jackson et al., 2003; Shannon et al., 2001) (c) autograft
procedures, such as ‘mosaicplasty’ (Hangody et al., 1998;
Kish and Hangody, 2004) or osteochondral autograft
transfer system (Attmanspacher et al., 2000), where
osteochondral cylindrical plugs are removed from a joint
area of minor load, such as the femoral trochlear groove,
and press-fitted into pre-drilled holes at the defect site
(van der Kooy and Weiss, 2000); (d) periosteal and
perichondrial transplantation to full-thickness cartilage
defects (Carranza-Bencano et al., 1999; O’Driscoll, 1998),
aimed at introducing undifferentiated periosteal cells into
the environments, leading to a source of chondrocytes;
(e) autologous cell transplantation (chondrocytes or
undifferentiated cells), previously expanded in vitro and
reinjected under an autologous periosteal flap, sutured
on the cartilage defect (Brittberg, 1999; Brittberg et al.,
1994; Gillogly et al., 1998).
Each of the above-mentioned treatments have been
shown to have limited success, as they are deficient
and inconsistent in long-term repair; moreover, they
also exhibit undesirable side effects and the treatments
are usually limited to small lesions, making the overall
outcome generally inadequate (Frenkel and Cesare, 2004;
Hunziker, 2000, 2002; Newman, 1998; Redman et al.,
2005). In fact, tissue transplantation inflicts further
tissue destruction before any therapeutic effect can be
achieved that is not guaranteed, as graft delamination
and endochondral ossification are frequently found;
moreover, drilling or surgical abrasion produces mainly
fibrocartilage at the defect site, which often deteriorates
with time.
Tissue engineering (TE) has emerged as a new mul-
tidisciplinary field, that joins the latest developments in
cell/molecular biology, materials science and engineering,
chemistry and medical sciences towards the develop-
ment of hybrid substitutes (combining biodegradable
supports, cells and signalling molecules, such as growth
factors) aimed at restoring tissue or organs functions,
using the natural signalling pathways and components of
the organism (Langer et al., 1993). Accumulating results
have shown that TE-based strategies have potential to
be used in the regeneration of a series of tissues and
organs (Atala, 2007) and are especially adequate for the
regeneration of articular cartilage, due to its own limited
repair capacity. Many studies have been published in this
context (Glowacki, 2000; Grande et al., 1999; Temenoff
and Mikos, 2000; Woodfield et al., 2002); however, most
of this work has reported solutions for the regeneration
of cartilage alone. In some situations there is the need
to consider the use of osteochondral implants contain-
ing both replacement cartilage and subchondral bone.
In the case of full-thickness defects, it would be desir-
able to use biphasic constructs, which could satisfy the
mechanical and biological requirements of both tissues.
Even in partial-thickness (chondral) defects, the use of
single scaffolds intended to regenerate cartilage may not
be effective, as it is difficult to integrate the implant with
the surrounding tissue. In that situation, a strategy could
consist of creating a full-thickness defect and a posterior
implantation of an osteochondral implant; this will help
to anchor the graft into the defect since, as commented by
Schaefer et al. (2000), a bone-to-bone interface integrates
better and faster than a cartilage-to-cartilage interface.
A critical requirement of cartilage TE is the correct
choice of the materials and the design of the scaffold
structure. Even for a single tissue, the ‘ideal scaffold’
does not yet exist, and much more investigative work
is needed on different materials combinations, the effect
of porosity (porosity content, pore size distribution and
interconnectivity), adequate cell sources and the best
delivery strategies for growth factors. The situation will
be complicated in the case of osteochondral constructs,
in which each layer has different specifications and their
contact must avoid any delamination or subsidence of the
scaffold in vivo.
In this review, some osteochondral TE strategies
that have been proposed are overviewed. Some topics
in this context are focused particularly, including the
new trends for scaffold design, the choice of the right
osteogenic/chondrogenic cell sources and materials and
the need for developing new culture methods.
2. Materials
In osteochondral approaches, many of the concepts that
have been proposed are based on the use of two distinct
materials, each one being adequate to integrate with
each tissue (see Figure 1 for the most widely accepted
strategy). Many types of materials have been proposed for
both cartilage and bone TE, most of them biocompatible
and biodegradable polymers that followed previous
applications in surgical procedures or other biomedical
applications. An exhaustive description is not given here;
much information may be found in other review papers
(Chen et al., 2002; Frenkel and Di Cesare, 2004; Gomes
and Reis, 2004; Salgado et al., 2004; Woodfield et al.,
2002). However, we can systematize the origin of relevant
materials in three major groups:
1. Natural-based polymers. Adequate materials for TE
applications should ideally mimic the naturally occur-
ring environment of the tissue, and natural polymers
usually contain domains that can send important
signals to guide cells at various stages of their develop-
ment (Galois et al., 2004; Langer, 1999; Mano et al.,.
in press; Thomson et al., 1995a). However, such bioac-
tivity can cause problems with antigenicity (Thomson
et al., 1995a) and the processability is often difficult.
The most used sources of natural derived polymers
Copyright  2007 John Wiley & Sons, Ltd. J Tissue Eng Regen Med 2007; 1: 261–273.
DOI: 10.1002/term
Osteochondral defects: present situation and TE approaches 263
Figure 1. Schematic representation of a osteochondral defect
showing the collagen fibres (left face) and the chondrocytes
(right face) of the cartilage layer (upper side), the bone region
(bottom), and the osteochondral implant
include proteins, especially from extracellular matri-
ces (e.g. collagen or glycosaminoglycan), polypeptides,
polysaccharides (including chitosan, starch, hyaluronic
acid and alginate) and poly(hydroxyalkanoates).
2. Synthetic polymers. Such systems offer a wide range of
chemical and processability variety, and in some cases
may be obtained with controlled distribution of molec-
ular weights. The most popular biodegradable syn-
thetic polymers include poly(α-hydroxy acids), espe-
cially poly(lactic acid) (PLA), poly(glycolic acid) (PGA)
and their co-polymers (PLGA), poly(ε-caprolactone),
poly(propylene fumarate), poly(dioxanone), poly-
orthoesters, polycarbonates, polyanhydrides and poly-
phosphazenes. Natural and synthetic polymers have
their own specificities, and we believe that the right
combination of both can bring together the advantages
of the two kinds of materials, offering more possibil-
ities to produce superior solutions. Another strategy
that one should have in mind is to look for materi-
als selection beyond the currently available materials
that were developed originally for other applications.
The design should have a bottom-up approach and the
materials should be able to recognize or be recognized
by the tissue environment, and react accordingly, and
also mimic the extracellular matrix to help guide mor-
phogenesis and tissue repair. An elegant example is
the development of hydrogels that have cell-mediated
proteolytic invasiveness capability (Lutolf et al., 2003).
Another fundamental issue, which will be not devel-
oped here, is surfacemodification of devices that allows
to the biological response to be tailored while main-
taining the bulk properties of the materials.
3. Ceramics, glasses and composites. Many studies have
been devoted to the understanding of the funda-
mentals of biomineralization and the use of such
knowledge in developing biomaterials with improved
properties for bone TE (Reis et al., 2004). Ceram-
ics, such as hydroxyapatite (HA) or other calcium
phosphate (Ca-P) ceramics (including tricalcium phos-
phate, TCP) or bioactive glasses (such as Bioglass)
are known to promote, when implanted, the formation
of a bone-like apatite layer on their surfaces. This is
considered to be a positive characteristic in terms of
bone-bonding behaviour, assuring enhanced fixation of
the implant (Huang et al., 1997; Li et al., 1992, 1997;
Oonishi, 1991; Peitl et al., 1996). The inorganic phase
can be combined with polymers or polymer precursors
that will allow produce bioactive, inert, biodegrad-
able or injectable composites to be produced (Mano
et al., 2004). Much effort has been expended in find-
ing new strategies for creating Ca-P coatings similar to
bone apatite, through biomimetics or other processing
routes, even in biomaterials that are not a priori bioac-
tive (Oliveira et al., 2003; Reis and Weiner, 2004).
Inclusion of growth factors in the scaffolds may be a
route for its controlled delivery during the differenti-
ation process. An interesting concept is the inclusion
of cytokines or morphogenetic factors, such as BMP-2,
into biomimetic Ca-P coatings (Liu et al., 2005). Note,
in the context of osteochondral TE, that the region
of the implant that will be in contact with the bone
should have bioactive behaviour, but one should avoid
any calcification on the cartilage side.
3. Scaffold design and processing
Scaffolds will provide a shape, guide tissue development
and permit the convenient delivery of cells into patients.
Whatever the tissues under consideration, the scaffolds
should ideally be biodegradable and the degradation
rate should match the extracellular matrix produced.
Generically, three-dimensional (3D) porous scaffolds or
hydrogels are the most widespread solutions for TE
constructs, due to the high standard of cellular attachment
and mechanical stability that is attained. Besides the
materials and subsequent surface modification, the
macrostructure of the scaffolds plays an important role,
not only in the resulting mechanical properties but also
on the proliferation and migration of seeded cells into
the matrix. For the particular case of bone formation
in vitro and in vivo, the role of porosity and pore size was
reviewed by Karageorgiou and Kaplan (2005).
Many techniques have been used to produce scaffolds,
and in most cases they can be used for both bone and
cartilage TE; they include: solvent casting and particulate
leaching (Agrawal et al., 1997; Holy et al., 2000; Lin et al.,
2002; Mikos et al., 1994; Murphy et al., 2002; Yoon and
Park, 2001), phase inversion/inversion (Holy et al., 2000;
Karp et al., 2003; Mooney et al., 1996), fibre bonding
(Gomes et al., 2003; Guidoin et al., 2000; Hutmacher,
2000; Kim and Mooney, 1998; Li et al., 2001; Mikos
et al., 1993a; Vunjak-Novakovic et al., 1998), melt-based
technologies (Gomes et al., 2001, 2002; Thomson et al.,
1995b; Washburn et al., 2002), membrane lamination
(Mikos et al., 1993b), high pressure-based methods
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(Mooney et al., 1996; Shea et al., 2000), supercritical
fluid technologies (Quirk et al., 2004), freeze drying
(Madihally and Matthew, 1999; Mao et al., 2003; Schoof
et al., 2001) and rapid prototyping techniques/free-form
fabrication (Hutmacher, 2000; Hutmacher et al., 2004;
Leong et al., 2003; Park et al., 1998; Woodfield et al.,
2004; Zhang et al., 2005).
As discussed further below, many TE concepts
dealing with osteochondral repair involve the design
of bilayered scaffolds that could regenerate both
cartilage and subchondral bone. Most of the processing
techniques already mentioned may be used, but different
combinations of materials and morphologies in both
sides of the scaffold will complicate the production
of such structures. This aspect will be analysed in
more detail in Section 5; here, just a few generic
and representative examples will be given. Moreover,
osteochondral constructs are typically fabricated in the
shape of a cylinder, which is more appropriate to address
the clinical needs of replacing localized arthritic defects.
Kawanishi et al. (2004) combined two different
processing techniques to obtain PLGA scaffolds with two
layers exhibiting different morphologies. A 1,4-dioxane
solution of PLGA was added to a mould containing
trisodium citrate particles in the bottom; as the level
of the solution was higher than the thickness of the
particle layer, freeze-drying followed by the leaching
of the particles allowed a bilayered structure with two
distinct porous organizations to be obtained. In another
study, it was shown that it is possible to develop 3D porous
bilayer hydroxyapatite–chitosan scaffolds by combining
a sintering and a freeze-drying technique (Ghosh et al.,
2006; Oliveira et al., 2006): The HA scaffolds, aimed to be
integrated into the bone side, were obtained by sintering
a polyurethane sponge filled with an HA slurry; a viscous
chitosan solution was added into the top of the ceramic
scaffold and the corresponding porous structure, adequate
for the cartilage side, was produced by freeze-drying. This
method allowed the two layers to be well integrated, as
the chitosan partially penetrated into the top region of
the ceramic scaffold. Good integration was obtained by
combining two layers with a common thermoplastic; the
bottom layer, comprising PLA reinforced with HA, and
the top layer, comprising a blend of starch and PLA, were
processed by compression moulding after compounding
with salt particles (Ghosh et al., 2006). A partial overlap
between the two layers was obtained and the two layers
exhibited physicochemical features adequate for both
tissues. Taguchi et al. (2004) developed a scaffold with
gradient calcium phosphate, using an alternative soaking
methodology in type II collagen gels that had one side
masked with a silicone sheet. This procedure enabled
gels to be obtained in which one of the half sides was
much richer in calcium phosphate, thus apparently being
more appropriate for integration into the subchondral
bone. Such examples clearly demonstrate the variety of
possibilities that exist in producing scaffolds aimed for
use in TE for the regeneration of osteochondral defects.
The use of injectable scaffolding materials is a more
recent and promising approach to be employed in
osteochondral TE. For example, Kang et al. (2006)
mixed rabbit chondrocytes with PLGA microspheres and
injected this mixture into full-thickness wounds made in
the knees of rabbits; 16 weeks after transplantation it
was observed that the chondrocytes were able to form
white cartilaginous tissue, indicating the potential of
this procedure in osteochondral wound repair. Another
approach in this context was the development of a thermo-
reversible hydrogel of P(NIPAAm-co-AAc) and hyaluronic
acid, which were used as injectable carriers of rabbit
chondrocytes and a growth factor (Na et al., 2007); the
results again showed that this system could also be
promising for the induction of neocartilage formation,
especially in the presence of the growth factor.
4. Cells
The choice of an adequate cell source is critical in
any TE strategy based on autologous cells. TE of
osteochondral parts is constrained by the need for the
growth and function of two different tissues – cartilage
and bone – despite deriving from common progenitor
cells. In osteochondral TE approaches some authors opted
to use, for example, just chondrocytes in the region of
the scaffold that will be integrated with cartilage (see
examples in next section). However, scaffolds seeded
with both osteoprogenitor and chondroprogenitor cells
may be needed to achieve enhanced integration with the
host tissues and mechanical function, especially in large
defects.
The most direct cell source is obtained from the
isolation of mature cells (osteoblasts and chondrocytes)
throughout biopsies taken from the patients, followed
by an expansion in vitro. However, the number of cells
that can be harvested is low and the expansion rates
of the cells are also relatively small, which will limit
the amount of cells available to be seeded onto the
scaffolds. The expansion of primary cells may also
result in a degradation of their functionality, e.g. the
expansion of articular chondrocytes can lead to the
expression of fibrocartilage (Lipman et al., 1983). Such
drawbacks may be surpassed using undifferentiated stem
cells. The use of such undifferentiated cells could be
a suitable way to use a single autologous cell source
in osteochondral approaches, which may provide both
kinds of cells needed while eliminating the risk of
immunological rejection and transmission of infectious
diseases. A discussion that should be raised in this context
is the use of growth factors, polypeptides that can either
stimulate or inhibit cellular proliferation, differentiation,
migration, adhesion and gene expression, by upregulating
or downregulating the synthesis of proteins, cytokines
and receptors (Jadlowiec et al., 2003; Rose and Oreffo,
2002). Such molecules could be directly loaded during
or after scaffold fabrication, and several strategies have
Copyright  2007 John Wiley & Sons, Ltd. J Tissue Eng Regen Med 2007; 1: 261–273.
DOI: 10.1002/term
Osteochondral defects: present situation and TE approaches 265
been proposed for growth factor delivery (Babensee et al.,
2000; Rose et al., 2004). As reviewed by Woodfield et al.
(2002), it has been proposed that cartilage growth and
maturation is supported by growth factors, including
insulin-like growth factor-1 (IGF-1), transforming growth
factor beta-1 (TGF-β1), fibroblast growth factor-2 (FGF-2)
and bone morphogenetic proteins (BMP-2 and BMP-3).
The delivery of more than one growth factor may be
beneficial; in a particular study, Holland et al. (2007)
investigated the delivery of single and dual growth factors
(TGF-β1 or IGF-1) in cartilage repair. Like cartilage,
bone also possesses a large variety of growth factors,
including TGF-β, BMP-2, -4, -6 and -7, IGF-1 and -2
and platelet-derived growth factor (PDGF; see further
discussion in Salgado et al., 2004), being also involved in
the regenerative process. For osteochondral approaches,
one clearly needs the controlled delivery of various growth
factors, with different delivery rates at different sites of
the scaffold, so that the right signals may be transmitted
for both kinds of tissue.
Stem cells may have different origins and have the
possibility, under certain conditions and with different
potential, to give rise to specialized cells of body
tissues and organs. Pluripotent embryonic stem cells
(ES cells), first isolated from the inner cell mass of the
blastocyst (Evans and Kaufman, 1981; Martin, 1981), are
characterized by two unique properties, a nearly unlimited
self-renewal capability and a capacity to differentiate via
precursor cells. Although there is enormous potential
for biomedical and TE applications of such cells, there
are still several issues to be addressed, including the
tumorigenic potential of ES cell-derived somatic donor
cells, or their immunological incompatibility, and ethical
and social questions associated with the use of ES cells in
regenerative medicine.
Well accepted by society, mesenchymal stem cells
are also capable of differentiation along multiple
mesenchymal lineages (Jorgensen et al., 2004) and are
present in many adult mesenchymal tissues, including
bone marrow (Tuan et al., 2003). Discussions on the
biological aspects of such cells, including their expansion
and differentiation potential, were reviewed by Gregory
et al. (2005). Bone marrow stromal cells (BMSCs) can
be regarded as a mesenchymal progenitor cell population
derived from adult stem cells. BMSCs can be obtained
in large numbers in culture if the right conditions are
provided, e.g. it was found that the proliferation and
maintenance of differentiation potential in these cells may
be achieved through FGF-2 supplementation to the culture
medium (Martin et al., 1997). Some authors consider
BMSCs to be the most interesting cell system for use in
connective TE (Cancedda et al., 2003).
Adipose tissue is also an abundant and accessible
source of adult stem cells, which can be isolated from
liposuction waste tissue by collagenase digestion and
differential centrifugation (Gimble and Guilak, 2003a,
2003b). It has been shown that human adipose-derived
stem cells are multipotent, capable of differentiating
along adipocyte, chondrocyte, neuron, osteoblasts and
skeletal myocyte pathways (Erickson et al., 2002; Gimble
and Guilak, 2003a, 2003b; Halvorsen et al., 2001; Zuk
et al., 2001, 2002). Therefore, they could also be a very
interesting source of progenitor cells with potential for
use in osteochondral therapy.
5. Tissue engineering strategies
5.1. Single-layered scaffolds
Some authors suggest that osteochondral implants could
be constructed from single-layer scaffolds. The typical
concept here consists of seeding autologous chondrocytes
in the top of the three-dimensional scaffold to create
a cell–scaffold construct for in vivo implantation. For
example, experiments were made using sheep models,
where β-TCP bioceramic scaffolds were used to support
autologous chondrocytes extracted from the humeral
head (Guo et al., 2004); although no long-term in vivo
studies were reported, these strategies were able to lead
to the formation of neocartilage tissue on the surface,
where hyaline cartilage structure was typically generated
after 24 weeks. In another study, hyaluronan-based
scaffolds coated with fibronectin were also seeded, or
not, with autologous bone marrow prior to implantation
in osteochondral defects of New Zealand white rabbits
(Solchaga et al., 2002). The hypothesis was that bone
marrow contains osteochondral progenitor cells and
bioactive agents that could induce the reconstruction
of both cartilage and bone in such defects, when
supported by the scaffold. Four weeks after implantation,
the defects were filled with bone, well integrated to
a top layer of cartilage. However, this study showed
that the inclusion of bone marrow in the scaffolds
did not reveal statistically superior performance with
respect with the control without cells, as judged from
histological scores of the specimens. Another study in this
context was performed in order to compare hyaluronan-
based scaffolds, with two different degradation rates,
and two polyester-based scaffolds, also with two distinct
degradation rates (Solchaga et al., 2005). This work
showed that the degradation profile is a critical parameter
for the repair process. Thicker cartilage is formed in slowly
dissolving scaffolds, although presenting more cracks and
discontinuities, and bone formation is also delayed at the
base of the defects.
Other strategies can be used to maintain the chon-
drocytes in the top of the scaffold. van Susante et al.
(1998) suspended isolated chondrocytes in fibrin glue.
This cell–glue suspension was loaded onto a HA cylindri-
cal scaffold that would integrate the subchondral bone.
Although some hyaline-like cartilage could be detected
at the HA–glue interface, a layer of fibrous tissue was
formed surrounding the HA graft, destabilizing the fix-
ation of the implant. Moreover, this strategy led to
a resurfacing of the joint with essentially fibrocarti-
laginous repaired tissue. Another procedure was used
by Wang et al. (2004) to produce neocartilage on the
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top on scaffolds from different origins – poly(L-lactide),
poly(D,L-lactide) and collagen-HA. Porcine chondrocytes
were seeded on the top of the scaffolds in adapted
cylindrical dialysis chambers. After 15 weeks, a viable
neocartilage layer was formed on each material, where,
comparatively, collagen–HA constructs were found to
be superior to the other formulations in terms of cell
viability, construct shape and cellular integration. Also,
the top of demineralized bone matrix gelatin scaffolds
were seeded with rabbit chondrocytes and cultivated for
6 weeks (Li et al., 2006); different characterization tech-
niques were used to demonstrate that viable hyaline-like
neocartilage tissue could also be produced on the con-
struct.
In another study, Tuli et al. (2004) press-coated a
chondrifying high-density pellet of trabecular bone-
derived human mesenchymal progenitor cells onto a
PLDLA scaffold. This construct was maintained in
a chondrogenic medium and subsequently loaded in
the other extremity with cells from the same source
but previously initiated to undergo osteogenesis. The
ensemble was then cultured in a cocktail medium that was
able to maintain both chondrogenesis and osteogenesis.
This is one of the few studies, with very encouraging
in vitro results, where a single source of human progenitor
cells was used to produce a osteochondral hybrid
construct. Clearly, more studies are needed in that
direction, combining different materials and scaffold
architectures, and optimized media should be developed
to allow for co-cultures.
Single-material scaffolds may be processed with a spe-
cific design that could be adequate for osteochondral
applications, e.g. using rapid prototyping techniques.
Fused deposition modelling is adequate to fabricate
reproducible and computer-controlled porous architec-
tures, where the two sides of the osteochondral construct
may have distinct structures and shapes (Cao et al.,
2003; Hutmacher, 2000). This aspect was analysed using
polycaprolactone-based honeycomb-like scaffolds, where
both osteogenic and chondrogenic cells were seeded
separately in the two regions of the scaffolds and cul-
tivated in a co-culture medium (Cao et al., 2003); it
was found that the cells proliferate in their compart-
ments for more than 50 days and produce extracellular
matrix.
In order to investigate the influence of the age of
donor cells and the age of the host on osteochondral
repair, cells derived from perichondrium were cultured
in a PLA scaffold and transplanted into osteochondral
defects of adult or aged female rabbits (Morihara
et al., 2002). For such fundamental studies where just
one question is addressed, simple protocols such as
this one seem to be preferable. Another example in
this context is the study the effect of transforming
growth factor-β1 (TGF-β1) on the development of
osteochondral tissue (Angele et al., 1999): it was found
that preculture in a chondrogenic medium increased the
formation of new tissue in hyaluronan–gelatin composite
constructs.
5.2. Bilayered scaffolds
Although single-material scaffolds may be easier to
prepare, the simultaneous regeneration of two tissues
should involve adequate support for both kinds of
cells, which will interact differently with the same
material. Furthermore, articular cartilage is a complex
tissue, whose performance will be influenced by the
mechanical support of the subchondral bone (Radin and
Rose, 1986). Therefore, an alternative strategy should
include the construction of bilayered structures, especially
adequate to incorporate, in a favourable environment, two
types of cells requiring different chemical surroundings,
mechanical features and pore morphology. This would
allow guiding the growth of two different tissues,
satisfying the different biological requirements. Therefore,
heterogeneous structures should be built, in which one
of the sides promotes cartilage regeneration and the
other region, exhibiting different properties, is designed
to encourage bone integration. For example, the cartilage-
side layer should be more ductile and should have much
more fluid uptake capability. The bone-side layer should
exhibit higher stiffness, should preferably have a good
affinity to the ceramic constituent of bone and, ideally,
should be able to induce vascularization, especially for
large defects. Ideally, adequate surfacemodification of the
pores in the two sides of the scaffold should be performed
independently, as chondrocytes and osteoblasts may react
differently to a given surface treatment of the biomaterial.
Three possible concepts are shown in Figure 2 for the
preparation of TE constructs based on bilayered scaffolds,
and some examples are given below.
5.2.1. Scaffolds from two independent layers
The easiest way to construct a biphasic scaffold is to
build the two layers independently and join them prior
the implantation (Figure 2A). Whether or not bioreactors
are used, this allows the cultivation of both chondrogenic
and osteogenic cells in separate media and environmental
conditions. The main disadvantage is that the integration
between the two layers may not be easily achieved.
For the bone layer, Niederauer et al. (2000) used
poly(D,L-lactic acid–co-glycolic acid) reinforced, or not,
with PGA fibres, Bioglass or calcium sulphate; for the
cartilage side, the same matrix was used, reinforced, or
not, with PGA fibres. The two phases were glued together
using a small amount of solvent. Half of the implants were
seeded with autologous goat primary chondrocytes and
implanted for 16 weeks after culture. In most cases a high
percentage of hyaline cartilage and good bone restoration
were found, in which case the addition of cells was found
not to significantly improve healing.
Kreklau et al. (1999) engineered a biphasic joint
cartilage, using a non-woven mesh consisting mainly of
PGA : PLA (9 : 1), previously seeded with bovine-derived
chondrocytes supported by a block of calcite or calcium
carbonate from coralline material. The cell–polymer
structure was affixed to the ceramic support with a
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Figure 2. Three possible strategies for constructing hybrid constructs for osteochondral TE: A – the cell culturing is performed
independently in two sides, that are integrated before implantation; B – two different cell sources are seeded in the two sides of
a bi-phasic scaffold, and cultivated in a special bioreactor with two separated chamber; C – common progenitor cells are seeded
in the two sides of a bi-phasic scaffold that contains different differentation agents and then cultivated in a bioreactor with two
chambers
fibrin–cell solution, and the hybrid constructs were
incubated in perfusion culture chambers. The polymer
hybrid construct formed a new matrix and fused with the
underlying biomaterial, but further in vivo tests would
be required to fully validate this concept; moreover,
it was not clear whether the use of bulk calcite
supports would be adequate in osteochondral repair.
Another example of integration of two layers using
fibrin sealant was the combination of a hyaluronan-based
sponge for the cartilage side, and a calcium phosphate
scaffold for the bone side (Gao et al., 2001). The two
layers were previously seeded with rat bone marrow-
derived mesenchymal stem cells and culture-expanded
separately in two different media that could stimulate
the differentiation of chondrocytes or osteoblasts. This
strategy allowed the formation of fibrocartilage in the
polymeric component, whereas bone was formed in
the ceramic layer. Fibrin glue was also used to join
two chitosan-based layers produced independently from
a particles aggregation methodology (Malafaya et al.,
2005): the bone-layer was produced from chitosan–HA
composite particles, whereas the cartilage layer was
produced using chitosan-only particles.
Schaefer et al. (2000) also used PGA-based materi-
als to produce osteochondral constructs: for the car-
tilage layer, chondrocytes were seeded on non-woven
PGA meshes, whereas periosteal cells were dynami-
cally cultured into PLGA–polyethylene glycol foams in
chondrogenic medium supplemented with osteogenic
medium. Both cartilaginous and bone-like constructs were
independently cultured for 1 or 4 weeks, sutured together
at two edges and cultured in osteogenic medium for
an additional 4 weeks. It was found that the bilayered
constructs were structurally stable. Moreover, the frac-
tion of glycosaminoglycan increased with time in the
cartilaginous region, whereas mineralization was pro-
duced in the bone layer during the isolated culture. In
another study, human chondrocytes and osteoblasts were
seeded separately in fibrous PGA disks that were sutured
together and cultured in a bioreactor (Mahmoudifar and
Doran, 2005a). Suturing was also used to join the chon-
dral and osteo layers, each one produced by lamination
of PLGA–collagen hybrid meshes (Chen et al., 2006b);
before suture and subcutaneous implantation in nude
mice, canine chondrocytes and canine bone marrow stro-
mal cells were cultivated in the two layers. Although
not implanted in osteochondral defects, the construct was
found by the authors to have potential to be used in TE, as
osteochondral-like tissue was found to be formed (Chen
et al., 2006b).
Both layers of an osteochondral construct may be
placed in the defect site through a press-fitting effect.
Schaefer et al. (2002) utilized two kinds of scaffold, a
non-woven mesh formed from PGA fibres with a void
volume of 97% for the cartilage side, and a sponge
made of bovine type I fibrillar collagen, HA and TCP
(Collagraft) as the subchondral support. Chondrocytes
were harvested from the articular cartilage of male New
Zealand white rabbits and dynamically seeded onto PGA
scaffolds in order to engineer cartilage. The subchondral
support allowed the fixation of the engineered cartilage
by press-fit. Four groups were tested: (a) the defect was
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left empty; (b) similar defects were treated with cell-
free osteochondral scaffold; (c) cartilage was engineered
over the Collagraft support; (d) defects were treated
with engineered cartilage and the Collagraft support,
onto which fresh bone marrow was adsorbed. That
study showed that such composites, when press-fitted
into large osteochondral defects in the animal model
utilized, withstood physiological loading and remodelled
over 6 months into osteochondral tissue with adequate
features. The integration with bone was positive, but the
composites did not integrate well with host cartilage. The
existence of bone marrow in the subchondral support did
not influence the tissue remodelling, i.e. group (d) vs.
group (c). Structurally, 6 month repairs in groups (c) and
(d) were superior to those in group (b), indicating the
importance of the previous culture of chondrocytes in the
top layer. Defects repaired with engineered cartilage-
based composites exhibited physiological mechanical
performance, compared with group (a), showing the
importance of the scaffold for the recovery of the
mechanical integrity of the defect.
Another approach for integrating the two layers is by
joining them through a biodegradable external fixation.
Schek et al. (2004) used layers of PLA and HA, processed
by solid free-form fabrication and seeded with fully
differentiated chondrocytes and fibroblasts transduced
with an adenovirus expressing bone morphogenetic
protein 7, respectively. The two phases were assembled
before cell seeding and subcutaneous implantation into
mice, using a thin PGA film between the layers, and PLA
rods that traversed the polymer and ceramic phases were
used to attach the two layers. This approach allowed the
simultaneous growth of bone, cartilage and mineralized
interface tissue.
In another strategy (Gao et al., 2002), the bone side of
an osteochondral defect of New Zealand white rabbits was
filled with a self-hardening injectable calcium phosphate.
As this is initially a paste, the material will fill the irregular
contours of the base of the defect, and it hardens at
temperatures of 20–37 ◦C, with biomechanical properties
similar to lamellar bone. Then a hyaluronan sponge,
previously loaded or not with autologous bone marrow-
derived progenitor cells, was inserted on the cartilage side.
After 12 weeks, repaired tissue composed by chondrocytes
arranged in a columnar array was observed on the
cartilage side. A higher cellular density was observed
in the healing tissue of the hyaluronan scaffolds loaded
with cells than in the control without cells. The ceramic
side also evidenced high osteoblastic/osteoclastic activity
and rapid new bone formation. Note that, in that case,
there was not a direct joining of the two layers but the
ensemble seemed to integrate well to the osteochondral
defect.
5.2.2. Integrated bilayered scaffolds
Different strategies may be envisaged to produce well
integrated bilayered porous osteochondral constructs
prior to cell culture. For example, two different sources
of cells can be seeded in the two layers before bioreactor
expansion (Figure 2B); alternatively, cells from a single
progenitor source are seeded in the scaffold, and the
differentiation and expansion will be accomplished during
culture (Figure 2C).
In a first concept, a gel (or gelling solution) suitable
for the selective growth of cartilage is impregnated
into one of the sides of a previously prepared bony
substrate. For example, it was suggested that agarose
could be an adequate vehicle to carry chondrocytes at
the top of devitalized trabecular bone disks from bovine
tibia (Hung et al., 2003). The suspension of bovine-
derived chondrocytes in agarose was added over the
ceramic scaffold and the hybrid construct was cultured
for 42 days after gelling. The chondrocytes remained
viable during this time, and the agarose maintained
its shape while remaining attached to the underlying
bony substrate. In this case, the agarose–cell suspension
could penetrate deeply into the construct. In another
study, Lima et al. (2004) reported simulation studies
in which large non-homogeneous mechanical signals
were found within such osteochondral constructs, that
could aid in the development of heterogeneity in the
mechanical environment felt by the cells seeded in the
engineered scaffolds. Similarly, dry ceramic cubes derived
from cancellous bone from calf femoral condyles were
soaked into a gelatin solution is such a way that one
of the extremities of the scaffold could be impregnated
by the solution through diffusion (Chang et al., 2004).
The gelatin was crosslinked with glutaraldeyede and a
biphasic construct was produced, as a portion of gelatin
was left outside the calcined bone scaffold. Porcine
articular chondrocytes were seeded in the gelatin layer
and the osteochondral scaffolds were cultured in a double-
chamber bioreactor; after 4 weeks, hyaline cartilage could
be observed in this region. A similar strategy, presented
previously, used a viscous chitosan solution that partially
impregnated a ceramic scaffold to produce a bilayered
structure (Oliveira et al., 2006). By changing the viscosity
of the chitosan solution, the degree of penetration into
the bone layer could be controlled, as well as the
porous structure of the chitosan foam. Fibrin glue was
also tested as the cartilage part in hybrid scaffolds in
which poly(caprolactone) scaffolds acted as the bone
compartment (Shao et al., 2006); however, although
the synthetic polymer showed potential as a matrix for
osteochondral bone regeneration, the fibrin glue was
found not to be a functional scaffold for the reconstruction
of articular cartilage at a weight-bearing site.
Another strategy is based in the use of common
materials in the upper and lower layers. For example,
collagen was used in both a dense collagen layer aimed
to be in contact with bone and a porous collagen matrix
for the cartilage side, where chondrocytes were seeded
(Frenkel et al., 1997); histological data allowed the
conclusion that the implants containing cells presented
better results that the control implants without cells.
In another study, oligo[poly(ethylene glycol) fumarate],
with or without gelatin microparticles (intended to speed
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scaffold degradation through enzymatic digestion and to
deliver TGF-β1), was used to produce bilayered structures
(Holland et al., 2005). A two-step crosslinking procedure
enabled the composition of the two layers to be controlled
independently. This study was intended to evaluate how
the presence of growth factors in the layers affects
the regeneration of osteochondral defects in rabbits. No
significant variations were found in the development of
subchondral bone, but the inclusion of TGF-β1 in the top
layer appeared to exert some therapeutic effect on hyaline
cartilage formation. As noted previously, good integration
was also achieved using PLLA as a common material in
the two layers, in the top layer blended with starch
and in the bottom layer reinforced with HA, with the
layers connected through compression moulding (Ghosh
et al., 2006). Also, a polyester-based biphasic scaffold was
produced, in this case processed by a 3D printing process
(Sherwood et al., 2002): the upper cartilage region was
composed of D,L-PLGA–L-PLA, with 90% porosity, and
the bone portion consisted of a 55% porous L-PLGA–TCP
composite. The good transition between the two layers
prevented delamination. The osteochondral devices were
cultured rotationally by submerging in a tube, or top-
seeded by pipetting ovine articular chondrocytes onto
the top of the scaffold. Cartilage was formed in the
top region of the construct during a 6 week in vitro
culture period and the tensile strength of the bone region
was found to be of the same order as fresh cancellous
human bone. Finally, in another study, collagen was
used in both cartilage (collagen sponge) and bone
(PLGA–collagen composite scaffold) layers, where the
collagen fraction in the two regions was connected
(Chen et al., 2006a). The biphasic scaffolds were used to
culture canine-derived BMSCs that were then implanted
into a canine osteochondral defect; after 4 months of
implantation, cartilage- and bone-like tissues were formed
in the corresponding layers, indicating that the developed
scaffold could have potential for use in osteochondral TE
(Chen et al., 2006a).
The above-mentioned examples clearly demonstrate
that, despite the enormous variety of materials, scaffold
designs and cells that have been tested for osteochondral
TE, it is not yet clear which would be the most
advantageous strategies to adopted or pursue. In fact,
the reported studies have used specific scaffolds and
test conditions that could hardly be compared with one
another. Therefore, despite the great efforts that have
been made, more integrated work is needed to seek
improved methodologies that could be transposed to
clinical practice.
5.3. Bioreactors
It has been known for a long time that cells and tissues
react to external mechanical stimuli that can include grav-
itational and hydrostatic pressures, shear stresses caused
by fluid flow, acoustic waves and contractile forces exerted
from one cell to another. Janmey and Weitz (2004) very
elegantly reviewed several aspects of the effect of forces
in the behaviour and response of cells and provided a
valuable bibliography. Bone mechanotransduction and its
relevance in the biomaterials area was also well reviewed
by Sikavitsas et al. (2001). A huge number of studies
have demonstrated that the biological environment of
tissues such as bone and cartilage is highly influenced
by mechanical forces felt by the cells. Therefore, simi-
lar physiological conditions should be ideally reproduced
in vitro during cell culture within the scaffolds. Such
conditions can be obtained in adequate bioreactors that
also have other advantages, including enhancement of
the transport of nutrients towards the inner regions of
the scaffold and release of waste products, thus pro-
viding a correct mass transport rate. Different bioreactor
designs have been proposed to dynamically culture cells in
hybrid constructs, including spinner flasks, rotating-wall
bioreactors (that simulate the effect of microgravity) and
perfusion-based bioreactors (for a literature survey, see
e.g. Martin et al., 2004; Salgado et al., 2004; Sikavitsas
et al., 2001; for a review focusing on the use of biore-
actors in engineering osteochondral grafts, see Wendt
et al., 2005). There are also bioreactors that are basi-
cally designed to just apply forces to the scaffolds, e.g.
through compression loading (Demarteau et al., 2003a,
2003b; Hung et al., 2004; Kisiday et al., 2004; Lee et al.,
2003; Waldman et al., 2004), giving valuable fundamen-
tal insights on the effect of mechanical stress in tissue
formation.
Most bioreactors have been created to operate in
single scaffolds, and they could be used in osteochondral
constructs provided that the correct co-culture conditions
are used. As an example, it was suggested that a
simple recirculation bioreactor (Mahmoudifar and Doran,
2005b) could be used in double-layered PGA disks
seeded with chondrocytes and osteoblasts in each side,
where glycosaminoglycan could be detected just in the
cartilage layer and only the bone layer was mineralized
(Mahmoudifar and Doran 2005a).
Increased versatility may be achieved in osteochondral
TE if the two layers of the scaffold are cultivated
separately. This will be facilitated if the two layers
are initially separated (see possibility A in Figure 2).
If the two layers are already integrated and are to
be cultivated simultaneously (Figure 2B, C), then new
strategies must be adopted where typically a double
chamber should be used to differentiate the culture
conditions. A possibility for such a bioreactor is to separate
these two chambers by a hollowed wall where the central
part of the bilayered scaffold is fixed (Hutmacher, 2000);
in this design, the two sides of the scaffold will be in
independent contact with the corresponding medium and
each chamber will have its own tissue culture and gas
inlets and outlets. A system using such a strategy was
tested in a gelatin/calcium phosphate biphasic scaffold
described previously (Chang et al., 2004). This bioreactor
consisted of two tubular glass chambers, each having
four branch tubes, for medium inflow and outflow, for
oxygen ventilation, and an extra one for other functions
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whenever necessary. The chambers were separated by
a silicone rubber septum with several holes to hold the
biphasic scaffolds. The apparatus also allowed mixing of
the media and mechanical stimulation through magnetic-
bar stirring, and the entire system could be put into an
incubator. This bioreactor could then used to culture
both osteoblasts and chondrocytes, but in that study
only the latter were seeded in the gelatin side of the
scaffold.
6. Future challenges
A major goal in osteochondral TE is to be able
to promote tissue synthesis derived from progenitor
cells, preferentially from a single cell source, that
will be differentiated in the construct to chondrocytes
and osteoblasts. This will require the incorporation of
cell adhesion molecules and specific growth factors in
different regions of the construct for TE chondrogenesis
and osteogenesis. In this context, smarter systems should
be developed where such active molecules could be
released with specific profiles and at specific locations.
A corollary for that is the need for improved bioreactors
able to culture both regions simultaneously in separate
reservoirs and different conditions. Alternatively, single
chamber bioreactors could be used, provided that
optimizedmedia are effective to promote cell proliferation
in both compartments. New specifications are also
required in the bone region in order to allow for rapid
and correct vascularization. Co-culture of endothelial cells
may be a strategy to promote neo-angiogenesis, but the
correct conditions to achieve a functional hybrid construct
remain to be elucidated.
The materials, degradation profiles and architectures of
porous structure must be different in the different regions,
as different cells will require different 3D environments
to adhere, proliferate and guide extracellular matrix for-
mation. Many possibilities exist for producing optimized
scaffolds, and combinatorial approaches may be needed
to progress. The number of possibilities also increases fur-
ther if one opts to modify the surface of the pores, either
through physical or chemical routes, or to incorporate
active agents. This would provide an adequate and spe-
cific chemical environment that could induce and specify
differentiation of progenitor cells, enhance cell adhesion
and proliferation or induce mineralization in the bone
side.
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